Anne Li Feburary 11th, 2016
A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients. The test could help identify which patients given a transplant are likely to develop a potentially fatal complication, the researchers report in The Journal of Clinical Investigation Insight. In doing so, the test could “allow early intervention and potentially save many lives”, said lead researcher Professor James Ferrara from Mount Sinai School of Medicine. Bone marrow transplants, in which a patient’s blood stem cells are replaced with those from a donor, are given to some patients with blood cancer to cure their disease. But around half of patients who receive the procedure develop a serious and often fatal complication called graft-versus-host disease (GVHD).
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-02-09-magic-blood-test-could-make-bone-marrow-transplants-for-blood-cancer-safer